Sublingual Vitamin D: Does It Improve Absorption?

For most healthy adults, sublingual vitamin D does not meaningfully improve absorption compared to a standard capsule or tablet. A randomized, placebo-controlled trial comparing a sublingual spray to a capsule found both equally effective at raising blood vitamin D levels over six weeks. Where sublingual delivery genuinely shines is in people whose guts cannot absorb vitamin D normally, such as those with Crohn’s disease or other malabsorptive conditions. The story, then, is less about sublingual being universally better and more about it solving a specific problem for a specific group of people.

What the Evidence Shows in Healthy Adults

The best direct comparison we have comes from a randomized, placebo-controlled trial of 75 healthy volunteers who received either a sublingual spray, a capsule, or a placebo daily for six weeks. Both the spray and capsule groups saw a significant rise in blood vitamin D levels compared to placebo, and the two delivery methods were equally effective. The average daily increase was about 2 nmol/L per day in both groups, with individual rates of change overlapping substantially between the spray and capsule arms.¹

This is the finding that matters most for the average person considering a sublingual spray at the pharmacy. If your digestive system is working normally, the route the vitamin takes into your body does not appear to make a clinically meaningful difference. Vitamin D is fat-soluble and well absorbed from the small intestine in most people, so bypassing that route through the mucous membranes of the mouth does not add a measurable advantage. The spray is not worse, but it is not better either.

When Sublingual Delivery Actually Helps

The picture changes substantially for people who have trouble absorbing nutrients through their gut. Conditions like Crohn’s disease, celiac disease, short bowel syndrome, and surgical removal of portions of the intestine can all impair vitamin D absorption, sometimes severely. For these patients, swallowing a vitamin D capsule may do very little because the intestinal lining is damaged, inflamed, or simply missing the surface area needed to absorb it.

A case report described a patient with Crohn’s disease, malabsorption, and a new ileostomy whose vitamin D levels were normalized within two weeks using sublingual vitamin D2. The key finding was that sublingual delivery worked effectively even when intestinal absorption was compromised.² In another case, a patient who had failed to respond to conventional oral supplementation despite adequate dosing was switched to sublingual vitamin D3 drops. Her blood level climbed gradually to 28 ng/mL after 12 weeks and reached 37 ng/mL at one year, a substantial improvement from her prior deficiency.³

These are case reports, not large trials, and that limitation is worth acknowledging. Randomized controlled studies specifically comparing sublingual to oral vitamin D in malabsorption populations are scarce. But the logic is straightforward: if the gut is the bottleneck, delivering vitamin D through the mucous membranes of the mouth avoids that bottleneck entirely. The oral mucosa is rich in blood vessels and can absorb fat-soluble compounds directly into the bloodstream. For patients with malabsorptive conditions, the case reports show enough of a signal that clinicians have started using sublingual vitamin D as a practical workaround, especially since injectable vitamin D is not approved by the U.S. Food and Drug Administration and the only other reliable option for these patients is ultraviolet B light exposure.³

Why D3 Often Outperforms D2 in Sublingual Form

Vitamin D comes in two main forms: D2 (ergocalciferol, plant-derived) and D3 (cholecalciferol, animal-derived or from lichen). This distinction matters more than most people realize when it comes to sublingual use. In the case report described above, the patient was initially prescribed sublingual vitamin D2 at a high dose of 50,000 IU for eight weeks but had a suboptimal response. After switching to sublingual vitamin D3 drops at 4,000 IU twice daily, her levels improved meaningfully over time.³

This mirrors a broader pattern in vitamin D research: D3 tends to be more effective than D2 at raising and maintaining blood levels of 25-hydroxyvitamin D, the form your body uses to gauge your vitamin D status. The difference comes down to how the two forms are metabolized; D3 has a longer half-life in the blood and binds more effectively to the proteins that transport vitamin D through your system. If you are choosing a sublingual supplement, D3 is the form more likely to produce the result you are looking for, especially at everyday doses rather than the massive pharmacological loading doses sometimes used in clinical settings.

How Sprays Perform in Infants and Children

One population where sublingual or buccal sprays have drawn particular interest is infants and young children, partly because getting a baby to swallow drops reliably can be a messy and imprecise affair. A study of 243 infants in their first year of life found that those supplemented with a spray form of vitamin D had median levels of 24 ng/mL, compared with 21 ng/mL in infants receiving the traditional drop form. The difference was statistically significant, though both groups still had meaningful rates of deficiency.⁴

An important caveat here: this was not a randomized trial. Parents chose which form to give their infants, which introduces the possibility that the parents who chose the spray were also different in other ways, such as consistency of supplementation, overall health awareness, or sun exposure habits. Still, the higher levels in the spray group raise the possibility that the spray format leads to better real-world compliance simply because it is easier to administer. A spray into a baby’s cheek is faster and less likely to be spit out than drops squeezed from a dropper.

In older children with neurodisabilities, a small randomized trial compared a buccal spray delivering 800 IU daily to oral drops delivering 750 IU daily over three months. Both groups saw significant improvement in their vitamin D levels. The spray was not more effective than drops at raising blood levels, but satisfaction with the spray formulation was significantly higher among patients and caregivers.⁵ For children who struggle with oral medications due to motor difficulties, behavioral challenges, or feeding tubes, a spray to the inside of the cheek is a much simpler proposition.

Practical Advantages That Have Nothing to Do with Absorption

Even in populations where sublingual and oral vitamin D raise blood levels by the same amount, there are practical reasons someone might prefer a spray or sublingual drop. A systematic review of buccal vitamin D spray trials noted that the spray format may be preferred by people with swallowing difficulties, or by those already taking many pills who want to reduce their capsule burden.⁶ Think of someone on chemotherapy dealing with nausea, an elderly person with dysphagia, or a patient already managing a handful of daily medications. Removing one more pill from the routine is a small quality-of-life improvement that can add up.

Cost is another consideration, and the answer here might surprise you. A study of patients on home parenteral nutrition who were switched to buccal vitamin D found that a six-month course of the buccal preparation was about 38% less expensive than six months of oral cholecalciferol capsules, based on hospital pharmacy pricing.⁷ That said, retail pricing varies enormously depending on brand, concentration, and country. Over-the-counter sublingual sprays can cost several times more per IU than bulk vitamin D3 capsules in some markets. If cost matters and your gut absorbs normally, a basic capsule is hard to beat on value.

Sublingual Versus Buccal: Does the Distinction Matter?

You will see the terms “sublingual” and “buccal” used almost interchangeably in discussions of vitamin D sprays and drops, but they refer to slightly different locations in the mouth. Sublingual means under the tongue, where the tissue is thin and particularly rich in blood vessels. Buccal means the inner cheek lining. Both areas can absorb substances directly into the bloodstream, bypassing the stomach and intestines.

In practice, most vitamin D sprays are marketed as “sublingual” but are actually sprayed against the inner cheek, making them buccal in a strict sense. The clinical trials discussed throughout this article used both terms, and none found a meaningful difference based on exactly where in the mouth the spray landed. The oral mucosa as a whole is the relevant absorption surface, and whether you spray under your tongue or against your cheek is unlikely to change your outcome. What matters more is that the liquid stays in contact with the mucous membrane long enough to be absorbed rather than immediately swallowed. Most instructions suggest holding the spray in your mouth for a few seconds before swallowing, and that is reasonable advice regardless of which surface you target.

Who Should Actually Consider Sublingual Vitamin D

Given the evidence, sublingual vitamin D is not a necessary upgrade for most people. If you have a healthy digestive system and no trouble swallowing capsules, you can expect similar results from either format. The people most likely to benefit fall into a few identifiable groups:

• Malabsorption conditions: Crohn’s disease, celiac disease, short bowel syndrome, cystic fibrosis, or any condition that reduces the intestinal surface area available for absorption. These patients may not respond adequately to oral vitamin D and have limited alternatives.
• Post-bariatric surgery: Procedures like gastric bypass can dramatically reduce vitamin D absorption by shortening the digestive tract. Sublingual delivery avoids the altered anatomy entirely.
• Swallowing difficulties: Older adults with dysphagia, stroke survivors, people with neurological conditions affecting the throat muscles, or children with developmental disabilities who resist oral medications.
• Infants and young children: A spray can be easier to administer accurately than drops from a dropper, and the data suggests at least comparable levels in real-world use.
• Persistent deficiency despite adequate oral dosing: If you have been taking oral vitamin D at reasonable doses for months and your blood levels are not rising, poor absorption is one possible explanation worth discussing with your doctor. Sublingual delivery is a logical next step before more invasive investigations.

For everyone else, the choice between a capsule and a sublingual spray comes down to personal preference, price, and convenience. Neither format has a clear biological advantage when the gut is functioning normally.

Common Misconceptions About Sublingual Supplements

A persistent idea in wellness circles is that sublingual delivery is inherently superior for all supplements because it “goes straight to the bloodstream.” This framing borrows from the pharmacology of drugs like nitroglycerin, where sublingual administration is used specifically because the drug is destroyed by stomach acid or heavily metabolized by the liver on first pass. Vitamin D does not have this problem. It survives the stomach just fine and is absorbed effectively from the small intestine when the intestine is healthy. The “straight to the bloodstream” argument does not apply in the same way.

Another misconception is that sublingual vitamin D acts faster. In the healthy-volunteer trial, both the capsule and the spray raised blood levels at the same rate over the study period.¹ This makes sense when you consider that vitamin D is not a fast-acting drug. It needs to be converted by the liver and then the kidneys before it becomes biologically active. Whether it enters the blood through your cheek or your intestine, it still has to go through the same metabolic steps. You are not going to feel a difference an hour after spraying it under your tongue.

There is also a tendency to assume that if a little sublingual absorption is good, higher doses must be better. Vitamin D toxicity is rare but real, and the route of administration does not change the upper safety limits. Whether you get your vitamin D from capsules, spray, drops, or sunshine, the same caution about excessive supplementation applies. Blood testing remains the most reliable way to guide your dosing if you are taking high amounts or dealing with a condition that complicates vitamin D metabolism.

The Quality Control Problem with Sprays

One underappreciated issue with sublingual and buccal vitamin D products is consistency of dosing. A capsule contains a fixed amount of vitamin D sealed inside it. A spray, by contrast, depends on the pump mechanism delivering a consistent volume with each press, on the user aiming it correctly, and on the product maintaining its stability over time. Independent testing of over-the-counter vitamin D supplements has found that the amount of vitamin D per dose can vary from what is stated on the label, and spray formulations introduce additional variables that capsules do not have.

In a clinical setting, the sublingual products used in the case reports were pharmaceutical-grade preparations prescribed and monitored by physicians. Over-the-counter sprays sold as dietary supplements are subject to less rigorous manufacturing standards in most countries, including the United States, where they are regulated as food products rather than drugs. This does not mean all commercial sprays are unreliable, but it does mean the consumer has to do more homework. If precise dosing matters to your situation, particularly if you are managing a deficiency in the context of a malabsorptive condition, working with a clinician who can monitor your blood levels and adjust accordingly is worth the effort.